Nivestym (filgrastim-aafi) Injection, 480 mcg/0.8 mL Prefilled Syringe, 10/Package

Nivestym (filgrastim-aafi) is a leukocyte growth factor biosimilar to Neupogen, indicated to decrease the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy. Each prefilled syringe contains 480 mcg of filgrastim-aafi in 0.8 mL solution for subcutaneous or intravenous administration. Supplied as a package of 10 single-use prefilled syringes.